Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Boyko

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Gene|June 17, 2022
Male-specific coordinated changes in expression of miRNA genes, but not other genes within the DLK1-DIO3 locus in multiple sclerosisNatalia Baulina, Ivan Kiselev, Maxim Kozin, et al.
Multiple Sclerosis and Related Disorders|October 6, 2024
Different genome-wide DNA methylation patterns in CD4+ T lymphocytes and CD14+ monocytes characterize relapse and remission of multiple sclerosis: Focus on GNASIvan Kiselev, Olga Kulakova, Olga Baturina, et al.
Pharmaceutics|May 27, 2026
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot StudyAnna Kukushkina, Vladimir Rogovskii, Olga Zhilenkova, et al.
International Journal of Molecular Sciences|January 21, 2022
The Dual Role of the β<sub>2</sub>-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple SclerosisMikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
Journal of Neuroimmunology|May 17, 2021
The role of 5-HT<sub>2B</sub>-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosisAnastasiya Sviridova, Vladimir Rogovskii, Vladimir Kudrin, et al.
Frontiers in Neurology|August 8, 2022
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapyMikhail Melnikov, Dmitriy Kasatkin, Anna Lopatina, et al.
International Journal of Molecular Sciences|May 27, 2026
Glatiramer Acetate Therapy Induces DNA Methylation Changes in Immune Cells of Multiple Sclerosis Patients: A Pilot StudyIvan Kiselev, Olga Kulakova, Olga Baturina, et al.
Neurology and Therapy|November 18, 2021
Caregiver Involvement in MS: Duty or Disruption?Jürg Kesselring, Alexey Boyko, Alice Laroni, et al.
Life (Basel, Switzerland)|January 20, 2021
The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple SclerosisMadina Kozhieva, Natalia Naumova, Tatiana Alikina, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2011
Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacyJens Ingwersen, Orhan Aktas, Patrick Kuery, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Gene|June 17, 2022
Male-specific coordinated changes in expression of miRNA genes, but not other genes within the DLK1-DIO3 locus in multiple sclerosisNatalia Baulina, Ivan Kiselev, Maxim Kozin, et al.
Multiple Sclerosis and Related Disorders|October 6, 2024
Different genome-wide DNA methylation patterns in CD4+ T lymphocytes and CD14+ monocytes characterize relapse and remission of multiple sclerosis: Focus on GNASIvan Kiselev, Olga Kulakova, Olga Baturina, et al.
Pharmaceutics|May 27, 2026
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot StudyAnna Kukushkina, Vladimir Rogovskii, Olga Zhilenkova, et al.
International Journal of Molecular Sciences|January 21, 2022
The Dual Role of the β<sub>2</sub>-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple SclerosisMikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
Journal of Neuroimmunology|May 17, 2021
The role of 5-HT<sub>2B</sub>-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosisAnastasiya Sviridova, Vladimir Rogovskii, Vladimir Kudrin, et al.
Frontiers in Neurology|August 8, 2022
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapyMikhail Melnikov, Dmitriy Kasatkin, Anna Lopatina, et al.
International Journal of Molecular Sciences|May 27, 2026
Glatiramer Acetate Therapy Induces DNA Methylation Changes in Immune Cells of Multiple Sclerosis Patients: A Pilot StudyIvan Kiselev, Olga Kulakova, Olga Baturina, et al.
Neurology and Therapy|November 18, 2021
Caregiver Involvement in MS: Duty or Disruption?Jürg Kesselring, Alexey Boyko, Alice Laroni, et al.
Life (Basel, Switzerland)|January 20, 2021
The Core of Gut Life: <i>Firmicutes</i> Profile in Patients with Relapsing-Remitting Multiple SclerosisMadina Kozhieva, Natalia Naumova, Tatiana Alikina, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2011
Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacyJens Ingwersen, Orhan Aktas, Patrick Kuery, et al.
Pageof 7